Osteoporosis Risk

Osteoporosis affects over 75 million people, male and female, worldwide and places 1 out of every 2 women at risk of developing bone fractures. Unfortunately the disease is often not detected until it is well advanced and a bone fracture (most commonly the hip) may be one of the first symptoms. Early detection of osteoporosis can facilitate successful treatment and reduce the risk of further development of the disease.

 

The Osteoporosis Risk Assessment (NTx) is a urine test which measures the risk of osteoporosis by detecting the rate of bone resorption (breakdown) well before significant changes are obvious on bone mineral density scans.

 

Research indicates that elevated bone resorption is the primary cause of age-related bone loss and low bone mass is the major cause of osteoporosis.

 

The NTx marker can also be used to monitor the efficacy of anti-resorptive therapies such as hormone replacement (HRT) and/or calcium supplementation in postmenopausal women, individuals with osteoporosis and those with Paget's disease.

 

Osteoporosis is a lifestyle disease, and more information can be found in the 'Dis-ease' section of this website.